The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 21, 2020

Filed:

Nov. 01, 2018
Applicant:

Enzo Life Sciences, Inc., New York, NY (US);

Inventors:

Irina Lebedeva, Bronx, NY (US);

Wayne Forrest Patton, Dix Hills, NY (US);

Maciej Szczepanik, Mount Sinai, NY (US);

Yuejun Xiang, Hollis Hills, NY (US);

Praveen Pande, Holbrook, NY (US);

Assignee:

Enzo Life Sciences, Inc, Farmingdale, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/26 (2006.01); C09K 11/06 (2006.01); C12Q 1/37 (2006.01); C12Q 1/44 (2006.01); C12Q 1/48 (2006.01); C07D 311/08 (2006.01); C07D 491/052 (2006.01); C07D 491/20 (2006.01); C07D 493/10 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/26 (2013.01); C07D 311/08 (2013.01); C07D 491/052 (2013.01); C07D 491/20 (2013.01); C07D 493/10 (2013.01); C09K 11/06 (2013.01); C12Q 1/37 (2013.01); C12Q 1/44 (2013.01); C12Q 1/485 (2013.01); C09K 2211/1022 (2013.01); C09K 2211/1088 (2013.01); G01N 2333/902 (2013.01); G01N 2500/00 (2013.01); Y10T 436/18 (2015.01);
Abstract

Provided is a compound having the structure:(SIG)-(SI-MOD)where SIG is a signaling molecule, SI is a self-immolative structure bound to SIG such that SIG has a reduced signal relative to the signal of SIG without SI, MOD is a moiety bound to SI that is subject to modification by an activator, and m is an integer from 1 to about 10. When MOD is modified by an activator, SI is destabilized and self-cleaved from SIG such that SIG generates an increased signal. Also provided are methods of determining whether a sample, such as a cell, comprises an activator, such as a nitroreducase, using the compound. Further provided are methods of determining whether a mammalian cell is hypoxic using the compound where nitroreductase is the activator. A method of detecting a microorganism that comprises a nitroreductase using the compound where nitroreductase is the activator is also provided.


Find Patent Forward Citations

Loading…